TD Cowen analyst Phil Nadeau maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target of $525.00. The company’s shares closed yesterday at $486.22.

Our perceptions of body image are shaped by what we see from as early as seven years old, according to new research by Durham University (UK). These body ideals continue to be influenced by visual ...

Carla Connor (Alison King) gets a huge shock in Coronation Street next week when she learns that a dead body has been found ... Believing he was dead, she told DC Kit Green (Jacob Roberts ...

A year after high schoolers discovered a severed arm near a Babylon park, authorities charged four people in connection with the deaths and dismemberment of two victims, whose body parts were ...

Little Leaf Farms is recalling a specific lot code of its Southwest Salad Kits because of the potential presence of undeclared fish and wheat allergens. People who have an allergy or severe ...

Vertex Pharmaceuticals (VRTX) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted an opinion for the label expansion of Kaftrio in combination ...

"Our kits feature Nike DRI-FIT ADV technology — Nike's latest advanced-performance material innovation engineered for the body in motion ... additional motto or logo selected by the team ...

According to the IRS, COVID-19 home testing kits are an eligible medical expense under the tax code. Personal protective equipment (PPE), such as masks, hand sanitizer and sanitizing wipes ...

Fabrice Coffrini/AFP via Getty Images The Trump administration has destroyed the World Trade Organization’s Appellate Body, much to the dismay of those needing the certainty of a rules-based ...